Global Jet Lag Therapy Market 2017-2023: Market is

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
121
Global Jet Lag Therapy Market 2017-2023: Market is Anticipated to Grow Over $732 Million

Dublin, April 20, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Jet Lag Therapy Market - Analysis and Forecast (2017-2023) (Focus on Product, End User and Competitive Landscape)" report to their offering. This research study includes an extensive analysis of the jet lag therapy market, by product type, end users and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. The market report presents a detailed and investigative study of the entire market and provides a comprehensive insight into various forms of developments, trends and key participants.

Despite the stiff competition in the jet lag therapy market, the prospective growth is expected to be driven by favorable factors such as inception of safe and effective wearable devices, increase in compliance of wearable devices among end-users, minimal side-effects or complications, and increase in the number of travelers each year globally. Future market growth is particularly expected in China, India, Japan, Mexico, Brazil and other emerging countries where the market penetration of jet lag therapy market is substantially low as compared to market penetration in the Europe. While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section on competitive landscape, market share analysis, competitor benchmarking, and their positioning within the global jet lag therapy market. The answers to the following key questions can be found in the report:

  • What are the major market drivers, challenges and opportunities of the global jet lag therapy market and their use cases?
  • How is the jet lag therapy market evolving during the forecast period?
  • What are the driving and restraining factors in the jet lag therapy market?
  • What are the market shares of the leading segments and sub-segments of the global jet lag therapy market in 2016 and 2023?
  • How will each segment of the jet lag therapy market grow over the forecast period and how much revenue will these account for in 2023?
  • How will the market share of the leading companies change in 2016 and which country will lead the market in 2016?
  • How will the industry evolve during the period between 2017 and 2023?
  • What are the key developmental strategies implemented in different applications across all regions?
  • Which geographical region will lead the global jet lag therapy market by the end of the forecast period?
  • What are the market trends and key developments in this market?

The report includes the profiles of major players in the market that allows the readers to get an insight into the various industry trends. Some of the leading companies in the market are Re-Timer Pty Ltd., Lumie, Ayo, Valkee, Lucimed, Propeaq, Nature Bright, Philips, Northern Light Technologies and Verilux. Key Topics Covered: Executive Summary 1 Report Scope and Methodology 2 Market Overview 2.1 Introduction 2.2 Travel Direction and Time Zone 2.3 Jet Lag Treatment 3 Target Population 3.1 U.S. Circadian Rhythm Disorder Statistics 3.2 Global Air Passenger Statistics 3.3 Target Population Analysis 4 Market Dynamics 4.1 Overview 4.2 Market Drivers 4.3 Market Challenges 4.4 Market Opportunities 5 Competitive Landscape 5.1 Key Developments & Strategies 5.2 Market Share Analysis 5.3 Comprehensive Competitive Index (CCI) 5.4 Growth Share Matrix 6 Industry Insights 6.1 Patent Landscape 6.2 Legal Developments 7 Global Jet Lag Therapy market, By Products 7.1 Overview 7.2 Key Insights 7.3 Prescription Drugs 7.3.1 Branded Prescription Drugs 7.3.1.1 Provigil/Nuvigil 7.3.1.2 Ambien 7.3.1.3 Lunesta 7.3.1.4 Sonata 7.3.2 Other Drugs 7.4 Melatonin 7.5 Herbal and Natural Products 7.6 Medical Devices 7.6.1 Light Box 7.6.2 Wearable Devices 7.6.2.1 Re-Timer 7.6.2.2 Propeaq Glasses 7.6.2.3 AYO 7.6.2.4 Neuroon 7.6.2.5 Luminette 7.6.2.1 HumanCharger 7.6.3 Wearable Devices Market Revenue 7.6.4 Pipeline Wearable Devices 8 Global Jet Lag Therapy market, By End-User 8.1 Overview 8.2 Business Travelers 8.3 Cabin Crew 8.4 Athletes 8.5 Seasonal Travelers 9 Global Jet Lag Therapy market, By Geography 10 Company Profiles

  • Ayo (Novalogy)
  • Inteliclinic
  • Litebook Co. Ltd.
  • Lucimed
  • Lumie
  • Nature Bright
  • Northern Light Technologies
  • Propeaq
  • Re-Timer
  • Royal Philips
  • Valkee
  • Verilux, Inc.
  • Vielight Inc.

For more information about this report visit http://www.researchandmarkets.com/research/3k...al_jet_lag

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Drugs by Therapeutic Area

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 36

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 102

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 353

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 395

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 8

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 28

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading

Top 5 Most Recently Viewed Articles

Buena Vida y Salud ACO Celebrated for Value-Based Care Innovation

Updated Category News Views 120

Buena Vida y Salud ACO Achieves National Recognition Buena Vida y Salud ACO has garnered significant acclaim as a recipient of the prestigious 2024 NAACOS Excellence Awards. This recognition highlights the organization's successful dedication to value-based care, shaping effective healthcare solutions tailored for patient needs. Leadership and Commitment to...

Continue Reading
SSCP Lager Bidco AB Shares Insights in Quarterly Report

Updated Category News Views 162

SSCP Lager Bidco AB Shares Insights in Quarterly Report Introduction to the Interim Report SSCP Lager Bidco AB (publ) recently released an interim report detailing the developments from April 1 to June 30 of a specific year, highlighting significant milestones and financial performance. Key Highlights of the Interim Report In this latest report, SSCP Lager Bidco AB...

Continue Reading
Important Corrections to ForFarmers N.V. Shareholder Meeting

Updated Category News Views 167

Update on the Resolutions of ForFarmers N.V. Annual General Meeting In a recent communication regarding the resolutions from the Annual General Meeting of Shareholders at ForFarmers N.V., some critical information was initially misstated. This announcement focuses on clarifying these details to ensure transparency and keep our stakeholders well-informed. Corrections to...

Continue Reading
Strong Increase in U.S. House Prices Despite Rising Rates

Updated Category News Views 90

U.S. House Prices Show Remarkable Growth The latest data reveals that U.S. single-family house prices experienced a strong increase in September, presenting challenges for many potential homeowners due to rising costs. This upward trend in the housing market is noteworthy, particularly as mortgage rates have begun to climb. Monthly Price Adjustments According to the...

Continue Reading
Upbeat BidCo Increases Buyout Offer Price for Believe's Shares

Updated Category News Views 208

Upbeat BidCo Raises Its Public Buyout Offer for Believe In an exciting development for investors, Upbeat BidCo has decided to increase its public buyout offer for Believe to 17.20 euros per share. This decision reflects a commitment to maximizing shareholder value while ensuring the future growth of Believe, a prominent digital music company. Significant Premium on the...

Continue Reading